The 21 linked references in paper E. Anaev Kh., K. Fedorchenko Yu., M. Kushaeva E., A. Ryabokon' M., A. Kononikhin S., V. Barmin V., O. Pikin V., I. Popov A., E. Nikolaev N., S. Varfolomeev D., A. Chuchalin G., Э. Анаев Х., К. Федорченко Ю., М. Кушаева Э., А. Рябоконь М., А. Кононихин С., В. Бармин В., О. Пикин В., И. Попов А., Е. Николаев Н., С. Варфоломеев Д., А. Чучалин Г. (2017) “Диагностика заболеваний легких на основе протеомного анализа конденсата выдыхаемого воздуха // Diagnosis of respiratory diseases using the proteomic analysis of exhaled breath condensate” / spz:neicon:pulmonology:y:2017:i:2:p:187-197

  1. Konstantinidi E.M., Lappas A.S., Tzortzi A.S., Behrakis P.K. Exhaled Breath Condensate: Technical and Diagnostic Aspects.Scientific World Journal. 2015; 2015: 435160. DOI: 10.1155/2015/435160.
  2. Borrill Z.L., Roy K., Singh D. Exhaled breath condensate biomarkers in COPD. Eur. Respir. J. 2008; 32 (2): 472–486. DOI: 10.1183/09031936.00116107.
  3. Bloemen K., Hooyberghs J., Desager K. et al. Non-invasive biomarker sampling and analysis of the exhaled breath proteome. Proteomics Clin. Appl. 2009; 3 (4): 498–504. DOI: 10.1002/prca.200800095. Пульмонология. 2017; 27 (2): 187–197. DOI: 10.18093/086930189320173273231873197
  4. Lin J.L., Bonnichsen M.H., Nogeh E.U. et al. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Exp. Rev. Proteomics. 2010; 7 (3): 361–372. DOI: 10.1586/epr.10.9.
  5. Lim M.Y., Thomas P.S. Biomarkers in exhaled breath condensate and serum of chronic obstructive pulmonary disease and non-small-cell lung cancer. Int. J. Chronic Dis.2013; 2013: 578613. DOI: 10.1155/2013/578613.
  6. Nobakht M. Gh B.F., Aliannejad R., Rezaei-Tavirani M. et al. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers. 2015; 20 (1): 5–16. DOI: 10.3109/1354750X.2014.983167.
  7. Terracciano R., Pelaia G., PreianòM., Savino R. Asthma and COPD proteomics: current approaches and future directions. Proteomics Clin. Appl.2015; 9 (1–2): 203–220. DOI: 10.1002/prca.201400099.
  8. 1183/09031936.00142508. 10. Lee Y.T., Chen S.C., Shyu L.Y. et al. Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia.Clin. Chim. Acta. 2012; 413 (5–6): 630–635. DOI: 10.1016/j.cca.2011.12.010.
  9. Conrad D.H., Goyette J., Thomas P.S. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.J. Gen. Intern. Med. 2008; 23 (Suppl. 1): 78–84. DOI: 10.1007/s11606-007-0411-1.
  10. Чучалин А.Г., Синопальников А.И., Козлов Р.С. и др. Российское респираторное общество (РРО). Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ). Клинические рекомендации по диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых. Пульмонология. 2014; (4): 13–48.
  11. Kurova V., Anaev E., Kononikhin A. et al. Proteomics of exhaled breath: methodological nuances and pitfalls.Clin. Chem. Lab. Med. 2009; 47 (6): 706–712. DOI: 10.1515/ CCLM.2009.166.
  12. Hoffmann H., Tabaksblat L., Enghild J., Dahl R. Human skin keratins are the major proteins in exhaled breath condensate.Eur. Respir. J.2008; 31 (2): 380–384. DOI: 10.1183/09031936.00059707.
  13. Ghosh R., Maji U.K., Bhattacharya R., Sinha A.K. The role of dermcidin isoform 2: a two-faceted atherosclerotic risk factor for coronary artery disease and the effect of acetyl salicylic acid on it. Thrombosis. 2012; 2012: 987932. DOI: 10.1155/2012/987932.
  14. Stewart G.D., Skipworth R.J., Pennington C.J. et al. Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines. Br. J. Cancer. 2008; 99 (1): 126–132. DOI: 10.1038/ sj.bjc.6604458.
  15. Yano C.L., Ventrucci G., Field W.N. et al. Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. BMC Cancer. 2008; 8: 24. DOI: 10.1186/1471-2407-8-24.
  16. Leclerc E.A., Gazeilles L., Serre G. et al. The ubiquitous dermokine delta activates Rab5 function in the early endocytic pathway. PLoS One.2011; 6 (3): e17816. DOI: 10.1371/ journal.pone.0017816.
  17. Hasegawa M., Higashi K., Yokoyama C. et al. Altered expression of dermokine in skin disorders. J. Eur. Acad. Dermatol. Venereol.2013; 27 (7): 867–875. DOI: 10.1111/ j.1468-3083.2012.04598.x.
  18. Poschmann G., Sitek B., Sipos B. et al. Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol. Cell Proteomics. 2009; 8 (5): 1105–1116. DOI: 10.1074/mcp.M800422MCP200.
  19. Wei N., Deng X.W. The COP9 signalosome. Annu. Rev. Cell Dev. Biol.2003; 19: 261–286. DOI:10.1146/annurev.cellbio. 19.111301.112449.
  20. Wang Q., Li X., Ren S. et al. Serum levels of the cancertestis antigen POTEE and its clinical significance in nonsmall-cell lung cancer.PLoS One.2015; 10 (4): e0122792. DOI: 10.1371/journal.pone.0122792.
  21. Resar L. The high mobility group A1 gene: transforming 1. Konstantinidi E.M., Lappas A.S., Tzortzi A.S., Behrakis P.K. Exhaled Breath Condensate: Technical and Diagnostic Aspects.Scientific World Journal. 2015; 2015: 435160. DOI: 10.1155/2015/435160. 2. Borrill Z.L., Roy K., Singh D. Exhaled breath condensate biomarkers in COPD. Eur. Respir. J. 2008; 32 (2): 472–486. DOI: 10.1183/09031936.00116107. 3. Bloemen K., Hooyberghs J., Desager K. et al. Non-invasive biomarker sampling and analysis of the exhaled breath proteome. Proteomics Clin. Appl. 2009; 3 (4): 498–504. DOI: 10.1002/prca.200800095. 4. Lin J.L., Bonnichsen M.H., Nogeh E.U. et al. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Exp. Rev. Proteomics. 201